Quick Answer
Sunshine Biopharma Inc. reported Total Assets of $30.56 million for fiscal year 2024.
Sunshine Biopharma Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $30.56M | +11.8% |
| 2023 | $27.35M | -6.5% |
| 2022 | $29.24M | +1227.5% |
| 2021 | $2.20M | +110.7% |
| 2020 | $1.05M | +965.3% |
| 2019 | $98.1K | -91.4% |
| 2018 | $1.15M | +345.3% |
| 2017 | $257.5K | +299.8% |
| 2016 | $64.4K | -90.4% |
| 2015 | $673.3K | +369.4% |
| 2014 | $143.4K | +359.1% |
| 2013 | $31.2K | -76.8% |
| 2012 | $134.8K | +26.6% |
| 2011 | $106.4K | -48.7% |
| 2010 | $207.6K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $31.49M | +4.8% | -1.5% |
| June 30, 2025 | $31.97M | +9.1% | +9.5% |
| March 31, 2025 | $29.19M | -8.5% | -4.5% |
| December 31, 2024 | $30.56M | +11.8% | +1.7% |
| September 30, 2024 | $30.06M | +8.7% | +2.6% |
| June 30, 2024 | $29.30M | +3.1% | -8.1% |
| March 31, 2024 | $31.90M | +18.2% | +16.6% |
| December 31, 2023 | $27.35M | -6.5% | -1.1% |
- Sunshine Biopharma Inc. showed an increase of +11.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2024 period, Sunshine Biopharma Inc.’s total assets has grown by 14619.1% (from $207.6 thousand to $30.56 million).
- The most recent figure is from Sunshine Biopharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: